BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15507895)

  • 1. Matrix metalloproteinases in the vein wall.
    Kowalewski R; Sobolewski K; Wolanska M; Gacko M
    Int Angiol; 2004 Jun; 23(2):164-9. PubMed ID: 15507895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
    J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of aFGF/bFGF and FGF signaling pathway in the wall of varicose veins.
    Kowalewski R; Malkowski A; Sobolewski K; Gacko M
    J Surg Res; 2009 Jul; 155(1):165-72. PubMed ID: 19394961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycan-degrading enzymes in the varicose vein wall.
    Kowalewski R; Sobolewski K; Malkowski A; Gacko M; Rutkowska I
    Int Angiol; 2008 Dec; 27(6):529-35. PubMed ID: 19078917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of primary varicose veins.
    Lim CS; Davies AH
    Br J Surg; 2009 Nov; 96(11):1231-42. PubMed ID: 19847861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.
    Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K
    Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
    Gu W; Liu W; Yang X; Yuan X; Tian Y; Meng R; Zhao Q
    Eur J Dermatol; 2011; 21(5):717-21. PubMed ID: 21719403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth.
    Wolańska M; Sobolewski K; Bańkowski E; Jaworski S
    Gynecol Obstet Invest; 2004; 58(1):14-8. PubMed ID: 15004438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
    Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
    Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.
    Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L
    Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
    Chen L; Nakai M; Belton RJ; Nowak RA
    Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
    Kurzawski M; Modrzejewski A; Pawlik A; Droździk M
    Clin Exp Dermatol; 2009 Jul; 34(5):613-7. PubMed ID: 19508478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
    Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
    Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
    Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Matrix metalloproteinases and colorectal cancer].
    Roeb E; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):763-70. PubMed ID: 14685678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
    Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
    Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases-2, -3 and -9 in human term placenta.
    Demir-Weusten AY; Seval Y; Kaufmann P; Demir R; Yucel G; Huppertz B
    Acta Histochem; 2007; 109(5):403-12. PubMed ID: 17559909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.